tirzepatide hypertension Obesity treatment and management aren't two separate conversations anymore — see the outcomes from @easo_org 's 2026 conference data. #GLP1 #Semaglutide #Tirzepatide #ObesityMedicine #BloodPressure # Hypertension #CardiometabolicHealth Systolic blood pressure reduction with

Clinical trials show lower doses produce 710% weight loss on average, while 2.4 mg produces 15%but your individual response matters more than the average

However, the risk increases during transition age and adulthood follow-up, especially when other risk factors coexist [300]

From the kitchen side, those are signs that food and fluid deserve attention, not pride

This is exactly why we need Phase 3 trials and why calling something safe before long-term data exists is premature

Turns out I had gallstones and had to have emergency surgery to have my gallbladder removed

No serious cardiovascular events have been linked so far